{"DataElement":{"publicId":"2795891","version":"1","preferredName":"Chronic Graft Versus Host Disease Overall Severity Type","preferredDefinition":"A description of the overall severity of chronic graft versus host disease.","longName":"CGVHD_OVRL_SVRTY_TP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2795880","version":"1","preferredName":"Chronic Graft Versus Host Disease Overall Severity","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant and may affect multiple organs with manifestations similar to autoimmune diseases.  Onset is usually within three years of transplantation or immunologic manipulation._Including everything._Used of the degree of something undesirable e.g. pain or weather; also, strictness.","longName":"CGVHD_OVRA_SVRTY","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2512832","version":"1","preferredName":"Chronic Graft Versus Host Disease","preferredDefinition":"A graft versus host disease with symptoms appearing more than 100 days post-transplant.","longName":"C4981","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8985BC-2113-374B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2795878","version":"1","preferredName":"Overall Severity","preferredDefinition":"Including everything.:Severity; used of the degree of something undesirable e.g. pain or weather.","longName":"C25605:C25676","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A67270A-9B74-1F4C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-29","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-29","modifiedBy":"ONEDATA","dateModified":"2008-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A67270A-9B85-1F4C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-29","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2795869","version":"1","preferredName":"Graft Versus Host Disease Severity Type","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._Used of the degree of something undesirable e.g. pain or weather; also, strictness._Type; a subdivision of a particular kind of thing.","longName":"GVHD_SV_TP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Severe","valueDescription":"Severe","ValueMeaning":{"publicId":"2955376","version":"1","preferredName":"Severe","longName":"2955376","preferredDefinition":"Signs and symptoms of chronic GVHD limit function substantially despite appropriate therapy or are progressive through second line therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"767278B8-77EB-4D95-E040-BB89AD4364D6","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"767278B8-7803-4D95-E040-BB89AD4364D6","beginDate":"2008-10-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"ONEDATA","dateModified":"2009-10-21","deletedIndicator":"No"},{"value":"Mild","valueDescription":"Mild","ValueMeaning":{"publicId":"2955374","version":"1","preferredName":"Mild","longName":"2955374","preferredDefinition":"Signs and symptoms of chronic GVHD do not interfere substantially with function and do not progress once appropriately treated with local therapy or standard systemic therapy (corticosteroids and/or cyclosporine or FK 506)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"767278B8-77A7-4D95-E040-BB89AD4364D6","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"767278B8-77BF-4D95-E040-BB89AD4364D6","beginDate":"2008-10-31","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"ONEDATA","dateModified":"2009-10-21","deletedIndicator":"No"},{"value":"Moderate","valueDescription":"Moderate","ValueMeaning":{"publicId":"2955375","version":"1","preferredName":"Moderate","longName":"2955375","preferredDefinition":"Signs and symptoms of chronic GVHD interfere somewhat with function despite appropriate therapy or are progressive through first line systemic therapy (corticosteroids and/or cyclosporine or FK 506)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"767278B8-77C9-4D95-E040-BB89AD4364D6","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"767278B8-77E1-4D95-E040-BB89AD4364D6","beginDate":"2008-10-29","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"ONEDATA","dateModified":"2009-10-21","deletedIndicator":"No"},{"value":"No GVHD","valueDescription":"Negation Graft Versus Host Disease","ValueMeaning":{"publicId":"5580503","version":"1","preferredName":"Negation Graft Versus Host Disease","longName":"5580503","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41D13E08-B33D-2E95-E053-F662850ACE8B","latestVersionIndicator":"Yes","beginDate":"2016-11-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"41D13E08-B356-2E95-E053-F662850ACE8B","beginDate":"2016-11-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-21","modifiedBy":"ONEDATA","dateModified":"2016-11-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2795868","version":"1","preferredName":"Graft Versus Host Disease Severity Type","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.:Severity; used of the degree of something undesirable e.g. pain or weather.:Type; a subdivision of a particular kind of thing.","longName":"C3063:C25676:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A670340-59A4-1796-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-29","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-29","modifiedBy":"ONEDATA","dateModified":"2008-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A670340-59B5-1796-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-29","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-29","modifiedBy":"CCURATOR","dateModified":"2023-12-21","changeDescription":". Added PV &#34;No GVHD&#34; for MC. AK 11/21/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"cgvhd_onset_severity","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalInterpretation:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"CGVHD_SEVR_CAT","type":"C3D Name","context":"CCR"},{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"Overall severity of chronic G","type":"Preferred Question Text","description":"Overall severity of chronic GVHD:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2795891","type":"BRIDG Mapping Path","description":"PerformedObservation > PerformedClinicalIntepretation.value WHERE PerformedObservation > DefinedObservation.nameCode = \"assess severity\" AND PerformedObservation.targetAnatomicSiteCode = \"whole body\" AND PerformedObservation > AssessedResultRelationship > PerformedDiagnosis.value = \"GVHD\" AND PerformedDiagnosis.diseaseStatusCode = \"Acute\" AND AssessedResultRelationship.typeCode = \"assessment\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A6761DA-1E24-2BED-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-29","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-29","modifiedBy":"KUMMEROA","dateModified":"2021-08-18","changeDescription":". .1/9/14mn-added Bridg info. System generated def displayed as alt def. AK 12/6/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}